General Liver Disease Resources
Explore GLI's unique curated list of education, support, and tools for patients with liver disease and the people who support them.
Terms and acronyms you need to know
Global Liver Institute (GLI) is proud to partner with Smart Patients to create an online community for people and their families who are affected by liver disease
Information for doctors and patients on obtaining access to medicines that are in development, are being tested in clinical trials, or are not yet approved by the FDA.
Your comprehensive guide to the drug cost ecosystem powered by Biotechnology Innovation Organization
NIDDK conducts and supports research on many of the most common, costly, and chronic conditions to improve health
Working through offices in more than 150 countries, WHO staff work side by side with governments and other partners to ensure the highest attainable level of health for all people
Easily organize meals and help for friends & family in need
Specific Liver Disease Resources
Education, support, and tools to help you navigate your specific liver disease. Liver disease can be divided into six categories.
Looking for more?
Become part of GLI's Advanced Advocacy Academy, meeting September 21-22, 2018 in Washington, D.C.
Together, we can collaborate as a force that ensures that liver disease has its proper place on the global public health agenda.
Primary Biliary Cholangitis
This easy-to-use online tool was created in response to feedback from the community. It can help people living with PBC navigate the complexities of PBC with their healthcare team, and manage how the condition specifically affects them.
Empowering you to take an active role in tracking and monitoring all aspects of your primary biliary cholangitis
Primary Sclerosing Cholangitis
PSC Partners Seeking a Cure provides education and support to PSC patients, families and caregivers and raises funds to research causes, treatments and cures for primary sclerosing cholangitis.
Provide support and hope to patients and families affected by autoimmune hepatitis through disease education and provision of research opportunities.
- GLI's Liver Cancer Glossary (coming soon! See GLI's Liver Glossary)
Terms and acronyms you need to know regarding liver cancer
This podcast channel features a dramatic reading of stories from terminally ill cancer patient and oncologists from performed by a celebrity actor or artist, followed by a Q&A session with the author of the article, hosted by JCO consultant editor Lidia Schapira, MD, FASCO.
Join the Liver Cancer community to learn from other patients and caregivers affected by liver cancer.
Blue Faery's mission is to prevent, treat and cure primary liver cancer, specifically Hepatocellular Carcinoma, through research, education and advocacy.
To find a cure and improve the quality of life for those affected by cholangiocarcinoma.
Non-Alcoholic Fatty Liver Disease & Non-Alcoholic Steatohepatitis
The purpose of the NASH Council is to shine a spotlight and coalesce an expanded set of stakeholders, in addition to hepatology, around the urgency of developing mechanisms for quantifying and addressing the silent epidemic of fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in the U.S. and abroad. Current estimates are that as many as 1 in 4 people already have NAFLD or NASH yet these conditions are underrecognized, underdiagnosed, and undertreated.
Improving together the medical learning about NASH to better address its causes and consequences and serve patients
The staff at the Pediatric Liver Center in the Division of Gastroenterology, Hepatology and Nutrition at the Johns Hopkins Children's Center is committed to offering a comprehensive and compassionate approach to the diagnosis and management of pediatric liver disease.
The National Viral Hepatitis Roundtable (NVHR) is national coalition working together to eliminate hepatitis B and C in the United States.
NASTAD is a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world. Our singular mission is to end the intersecting epidemics of HIV, viral hepatitis, and related conditions. We do this work by strengthening domestic and global governmental public health through advocacy, capacity building, and social justice.